|
76
|
257
|
5sz6A |
Carbonic anhydrase ix-mimic in complex with 4-(3-formylphenyl)-benzenesulfonamide |
|
78
|
257
|
5sz1A |
Carbonic anhydrase ii in complex with 4-(2-methylphenyl)-benzenesulfonamide |
|
72
|
223
|
5swcA |
The structure of the beta-carbonic anhydrase ccaa |
|
75
|
259
|
5ohhA |
Crystal structure of human carbonic anhydrase isozyme xiii with 2-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-3,5,6-trifluoro-4-[(2-hydroxyethyl)thio]benzenesulfonamide |
|
80
|
259
|
5ogpA |
Metalacarborane inhibitors of carbonic anhydrase ix |
|
79
|
258
|
5ogoA |
Crystal structure of chimeric carbonic anhydrase i with 3-(benzylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide |
|
79
|
259
|
5ognA |
Metalacarborane inhibitors of carbonic anhydrase ix |
|
82
|
259
|
5ogjA |
Crystal structure of human carbonic anhydrase isozyme xiii with 2-(cyclooctylamino)-3,5,6-trifluoro-4-[(2-hydroxyethyl)thio]benzenesulfonamide |
|
75
|
258
|
5nxoA |
Carbonic anhydrase ii inhibitor ra6 |
|
76
|
259
|
5nxiA |
Carbonic anhydrase ii inhibitor ra2 |
|
78
|
257
|
5nyaA |
Carbonic anhydrase ii inhibitor ra13 |
|
77
|
258
|
5ny6A |
Carbonic anhydrase ii inhibitor ra12 |
|
78
|
258
|
5ny3A |
Carbonic anhydrase ii inhibitor ra11 |
|
78
|
257
|
5nxwA |
Carbonic anhydrase ii inhibitor ra9 |
|
79
|
258
|
5nxmA |
Carbonic anhydrase ii inhibitor ra1 |
|
75
|
256
|
5o07A |
The crystal structure of the human carbonic anhydrase ii in complex with a nitroimidazole sulfamate inhibitor |
|
77
|
258
|
5nxvA |
Carbonic anhydrase ii inhibitor ra8 |
|
76
|
257
|
5nxgA |
Carbonic anhydrase ii inhibitor ra1 |
|
78
|
258
|
5nxpA |
Carbonic anhydrase ii inhibitor ra7 |
|
77
|
257
|
5ny1A |
Carbonic anhydrase ii inhibitor ra10 |
|
79
|
258
|
5n1sA |
Crystal structure of human carbonic anhydrase ii in complex with the inhibitor 4-(1h-indol-2-yl)-benzenesulfonamide |
|
73
|
258
|
5l6tA |
Crystal structure of human carbonic anhydrase ii in complex with a quinoline oligoamide foldamer |
|
75
|
257
|
5lmdA |
The crystal structure of hca ii in complex with a benzoxaborole inhibitor |
|
69
|
259
|
5l9eA |
Crystal structure of human carbonic anhydrase ii in complex with a quinoline oligoamide foldamer |
|
72
|
259
|
5lvsA |
Self-assembled protein-aromatic foldamer complexes with 2:3 and 2:2:1 stoichiometries |
|
78
|
258
|
5brvA |
Catalytic improvement of an artificial metalloenzyme by computational design |
|
72
|
259
|
5l3oA |
Crystal structure of human carbonic anhydrase ii in complex with a quinoline oligoamide foldamer |
|
76
|
261
|
5j8zA |
Human carbonic anhydrase ii in complex with ligand |
|
76
|
258
|
5jepB |
Human carbonic anhydrase ii (t199s) complexed with benzo[d]thiazole-2-sulfonamide |
|
76
|
258
|
4yxuA |
Human carbonic anhydrase ii complexed with an inhibitor with a benzenesulfonamide group (4). |
|
73
|
258
|
5jdvB |
Human carbonic anhydrase ii (f131w) complexed with benzo[d]thiazole-2-sulfonamide |
|
75
|
258
|
4z1jA |
Carbonic anhydrase inhibitors: design and synthesis of new heteroaryl-n-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms (hca vii, hca ix, and hca xiv) |
|
74
|
259
|
4z1eA |
Carbonic anhydrase inhibitors: design and synthesis of new heteroaryl-n-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms (hca vii, hca ix, and hca xiv) |
|
72
|
257
|
4ywpA |
Sucrose binding site in genetically engineered carbonic anhydrase ix |
|
80
|
258
|
5g01A |
An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition and protein x-ray structure of psammaplin c |
|
75
|
257
|
4zwxA |
Engineered carbonic anhydrase ix mimic in complex with glucosyl sulfamate inhibitor |
|
80
|
257
|
4zx1A |
Engineered carbonic anhydrase ix mimic in complex with a glucosyl sulfamate inhibitor |
|
79
|
257
|
5g0bA |
An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition and protein x-ray structure of psammaplin c |
|
80
|
257
|
4zx0A |
Human carbonic anhydrase ii in complex with a glucosyl sulfamate inhibitor |
|
71
|
257
|
5gmnA |
Crystal structure of human carbonic anhydrase ii in complex with polmacoxib |
|
82
|
258
|
5g0cA |
An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition and protein x-ray structure of psammaplin c |
|
76
|
257
|
5gmmA |
Crystal structure of human carbonic anhydrase i in complex with polmacoxib |
|
79
|
257
|
5g03A |
An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition and protein x-ray structure of psammaplin c |
|
77
|
257
|
4zwiA |
Surface lysine acetylated human carbonic anhydrase ii in complex with a sulfamate-based inhibitor |
|
66
|
251
|
5fl6A |
Three dimensional structure of human carbonic anhydrase ix in complex with 5-(1-(4-methylphenyl)-1h-1,2,3-triazol-4-yl)thiophene-2- sulfonamide |
|
79
|
258
|
5fniA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
68
|
251
|
5fl4A |
Three dimensional structure of human carbonic anhydrase ix in complex with 5-(1-naphthalen-1-yl-1,2,3-triazol-4-yl)thiophene-2-sulfonamide |
|
73
|
258
|
4z0qA |
Carbonic anhydrase inhibitors: design and synthesis of new heteroaryl-n-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms (hca vii, hca ix, and hca xiv) |
|
80
|
258
|
5floA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
79
|
257
|
5flpA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
